June 24, 2018
Pennsylvania Convention Center
This free event offers patients and caregivers a unique opportunity to learn about the role of nuclear medicine in diagnosing and treating disease.
The morning sessions offer an overview of nuclear medicine, radiation safety, and clinical trials. This will be followed by lunch and breakout sessions specific to disease types. You'll also have an opportunity to tour the Society of Nuclear Medicine and Molecular Imaging exhibit hall to learn about current and emerging technologies and pharmaceuticals.
10:30 a.m. - 12:15 p.m.
- What is Nuclear Medicine and Molecular Imaging? Michael E. Phelps, PhD
- Radiation Safety, Frederic H. Fahey, DSc, FSNMMI
- How to Understand and Evaluate Clinical Trials, Emily Bergsland, MD
12:15 - 1:30 p.m.
Patient Empowerment Luncheon
1:30 - 2:15 p.m.
Exhibit Hall Tour 1 (for patients not attending afternoon breakouts)
1:30 - 3:15 p.m.
- Prostate Cancer
- J. Ryan Mark, MD, Urologist, Thomas Jefferson University Hospital, Philadelphia, PA
- Robert Flavell, MD, PhD, Assistant Professor, Nuclear Medicine, University of California San Francisco, San Francisco, CA
- Patient Speaker TBD
- Neuroendocrine Tumors
- Emily Bergsland, MD, Gastrointestinal Oncologist, University of California San Francisco, San Francisco, CA
- David Metz, MD, Co-Director, Neuroendocrine Tumor Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
- Dan Pryma, MD, Division Chief, Nuclear Medicine and Clinical Molecular Imaging, University of Pennsylvania, Philadelphia, PA
- Michael Hofman, MMBS, Nuclear Medicine Physician, Peter MacCallum Cancer, Melbourne, Victoria, Australia
- Josh Mailman, MBA, President, NorCal CarciNET Community, Ripon, CA
- Stephen Schwartz, SNMMI Patient Advocacy Advisory Board Chairman
- Additional Speakers TBD
3:15 - 4:00 p.m.
Exhibit Hall Tour 2
4:00 - 5:00 p.m.
Questions? Contact Linda Budzinski at email@example.com; 703.742.5498.